Vaxcyte Inc（PCVX）價格預測

$60.430

-2.327 (-3.85%)收盤時

價格預測

1-Day Price Prediction

+1.93%

1-Week Prediction

+1.64%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

PCVX 相似圖表分析預測

Alphio's PCVX stock price prediction model matches the current Vaxcyte Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $61.60 (+1.93%). The 1-week path is $61.42 (+1.64%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Vaxcyte Inc 股票嗎？

Vaxcyte Inc (PCVX) is a good buy right now due to its recent positive Phase 3 trial results for the VAX-31 vaccine, which led to a significant 60% stock surge, and analysts projecting a price target as high as $163, well above the current price of $60.43. The stock has shown a year-to-date increase of 30.07%, reflecting strong market interest and potential profitability. However, the main risk is the negative earnings trend, with projected EPS of -1.84 for the next earnings report, indicating ongoing financial challenges.

PCVX 股價於 Friday 收在 $60.43，此前下跌 -3.85%

Vaxcyte Inc (PCVX) last closed at $60.43, losing -3.85%. These facts feed the 1-day and 1-week PCVX price prediction above.

預測驅動因素

Vaxcyte Inc（PCVX）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Negative

Bearish

SMA 200

Positive

Bullish

相似圖表形態

近期走勢與 PCVX 最接近的股票，依相似度排序。

MRNA

90.32%

+44.89%

AES

90.10%

-4.19%

DECK

89.81%

-15.38%

PEGA

89.55%

+1.80%

THRM

89.47%

-7.44%

PCVX 季節性分析

Historically the probability of a positive October return for PCVX is 63.49%. February offers the highest probability of a positive month at 86.21%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…